Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
57.3M
-
Shares change
-
-369K
-
Total reported value, excl. options
-
$1.32B
-
Value change
-
-$9.97M
-
Put/Call ratio
-
1.81
-
Number of buys
-
76
-
Number of sells
-
-68
-
Price
-
$22.97
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q1 2023
187 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2023.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.3M shares
of 58.6M outstanding shares and own 97.64% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (5.72M shares), VANGUARD GROUP INC (5.42M shares), BlackRock Inc. (4.82M shares), Bellevue Group AG (4.01M shares), ARMISTICE CAPITAL, LLC (3.46M shares), STATE STREET CORP (3.06M shares), Rock Springs Capital Management LP (2.66M shares), FARALLON CAPITAL MANAGEMENT LLC (2.09M shares), DIMENSIONAL FUND ADVISORS LP (2.09M shares), and FIRST TRUST ADVISORS LP (1.84M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.